Imexpharm Revenue

Imexpharm had revenue of 594.06B VND in the quarter ending March 31, 2025, with 20.96% growth. This brings the company's revenue in the last twelve months to 2.31T, up 15.07% year-over-year. In the year 2024, Imexpharm had annual revenue of 2.21T with 10.59% growth.

Revenue (ttm)

2,308.08B

Revenue Growth

+15.07%

P/S Ratio

2.91

Revenue / Employee

1.60B

Employees

1,452

Market Cap

6,714.79B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2,205.12B	211.08B	10.59%
Dec 31, 2023	1,994.04B	350.33B	21.31%
Dec 31, 2022	1,643.71B	377.11B	29.77%
Dec 31, 2021	1,266.60B	-102.83B	-7.51%
Dec 31, 2020	1,369.42B	-33.03B	-2.36%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Joint Stock Commercial Bank for Foreign Trade of Vietnam	65.33T
Joint Stock Commercial Bank for Investment and Development of Vietnam	59.95T
Vinhomes JSC	102.32T
Vingroup JSC	189.07T
Vietnam Joint Stock Commercial Bank for Industry and Trade	54.31T
Vietnam Technological and Commercial Joint Stock Bank	42.91T
FPT Corporation	64.81T
Hoa Phat Group JSC	138.86T

Revenue Rankings